Cargando…

Design, synthesis and biological evaluation of covalent peptidomimetic 3CL protease inhibitors containing nitrile moiety

In this paper, a series of peptidomimetic SARS-CoV-2 3CL protease inhibitors with new P2 and P4 positions were synthesized and evaluated. Among these compounds, 1a and 2b exhibited obvious 3CL(pro) inhibitory activities with IC(50) of 18.06 nM and 22.42 nM, respectively. 1a and 2b also showed excell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Mengwei, Fu, Tiantian, You, Mengyuan, Cao, Junyuan, Yang, Hanxi, Chen, Xinyao, Zhang, Qiumeng, Xu, Yechun, Jiang, Xiangrui, Zhang, Leike, Su, Haixia, Zhang, Yan, Shen, Jingshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166615/ https://www.ncbi.nlm.nih.gov/pubmed/37187077 http://dx.doi.org/10.1016/j.bmc.2023.117316

Ejemplares similares

Design, synthesis and biological evaluation of peptidomimetic benzothiazolyl ketones as 3CL(pro) inhibitors against SARS-CoV-2
por: Yang, Hanxi, et al.
Publicado: (2023)

Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease
por: Su, Haixia, et al.
Publicado: (2021)

Structure-Based Design of Potent Peptidomimetic Inhibitors Covalently Targeting SARS-CoV-2 Papain-like Protease
por: Wang, Qian, et al.
Publicado: (2023)

In silico screening-based discovery of novel covalent inhibitors of the SARS-CoV-2 3CL protease
por: Xiong, Muya, et al.
Publicado: (2022)

Novel Nitrile Peptidomimetics for Treating COVID-19
por: Chia, C. S. Brian
Publicado: (2022)

Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir
por: Jiang, Xiangrui, et al.
Publicado: (2023)

Design, synthesis and crystallographic analysis of nitrile-based broad-spectrum peptidomimetic inhibitors for coronavirus 3C-like proteases
por: Chuck, Chi-Pang, et al.
Publicado: (2013)

Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic α,β-unsaturated esters
por: Shie, Jiun-Jie, et al.
Publicado: (2005)

Discovery of novel non-peptidic and non-covalent small-molecule 3CL(pro) inhibitors as potential candidate for COVID-19 treatment
por: Jiang, Zhidong, et al.
Publicado: (2023)

Discovery, synthesis and mechanism study of 2,3,5-substituted [1,2,4]-thiadiazoles as covalent inhibitors targeting 3C-Like protease of SARS-CoV-2
por: Ren, Pengxuan, et al.
Publicado: (2023)

Correction: Discovery of novel non-peptidic and non-covalent small-molecule 3CL(pro) inhibitors as potential candidate for COVID-19 treatment
por: Jiang, Zhidong, et al.
Publicado: (2023)

Protease inhibitors and their peptidomimetic derivatives as potential drugs
por: Fear, Georgie, et al.
Publicado: (2007)

Covalent Reversible Inhibitors of Cysteine Proteases Containing the Nitrile Warhead: Recent Advancement in the Field of Viral and Parasitic Diseases
por: Brogi, Simone, et al.
Publicado: (2022)

Placement of Hydroxy Moiety on Pendant of Peptidomimetic Scaffold Modulates Mu and Kappa Opioid Receptor Efficacy
por: Harland, Aubrie A., et al.
Publicado: (2017)

An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2016)

In vitro and in vivo evaluation of the main protease inhibitor FB2001 against SARS-CoV-2
por: Shang, Weijuan, et al.
Publicado: (2022)

Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety
por: Konno, Sho, et al.
Publicado: (2013)

Covalent Organic Frameworks with Ionic Liquid-Moieties (ILCOFs): Structures, Synthesis, and CO(2) Conversion
por: Zhang, Ruina, et al.
Publicado: (2022)

Peptidomimetics II
por: Lubell, William D
Publicado: (2016)

Computational study on peptidomimetic inhibitors against SARS-CoV-2 main protease
por: Somboon, Tuanjai, et al.
Publicado: (2021)

Evaluation of the Covalent Functionalization of Carbon Nano-Onions with Pyrene Moieties for Supercapacitor Applications
por: Velásquez, José D., et al.
Publicado: (2020)

Peptidomimetics in cancer targeting
por: Gomari, Mohammad Mahmoudi, et al.
Publicado: (2022)

Cysteine protease inhibition by nitrile-based inhibitors: a computational study
por: Quesne, Matthew G., et al.
Publicado: (2013)

Discovery of novel SARS-CoV-2 3CL protease covalent inhibitors using deep learning-based screen
por: Wang, Liying, et al.
Publicado: (2022)

Progress on SARS-CoV-2 3CLpro Inhibitors: Inspiration from SARS-CoV 3CLpro Peptidomimetics and Small-Molecule Anti-Inflammatory Compounds
por: Zhu, Jiajie, et al.
Publicado: (2022)

Development and Evaluation of Small Peptidomimetic Ligands to Protease-Activated Receptor-2 (PAR(2)) through the Use of Lipid Tethering
por: Boitano, Scott, et al.
Publicado: (2014)

Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element
por: Galasiti Kankanamalage, Anushka C., et al.
Publicado: (2018)

Efficacy and safety of SIM0417 (SSD8432) plus ritonavir for COVID-19 treatment: a randomised, double-blind, placebo-controlled, phase 1b trial
por: Wang, Fuxiang, et al.
Publicado: (2023)

Investigation of the Compatibility between Warheads and Peptidomimetic Sequences of Protease Inhibitors—A Comprehensive Reactivity and Selectivity Study
por: Müller, Patrick, et al.
Publicado: (2023)

Spectral Properties of Highly Emissive Derivative of Coumarin with N,N-Diethylamino, Nitrile and Tiophenecarbonyl Moieties in Water-Methanol Mixture
por: Kolbus, Anna, et al.
Publicado: (2019)

Photomotion of Hydrogels with Covalently Attached Azo Dye Moieties—Thermoresponsive and Non-Thermoresponsive Gels
por: Jaik, Thorben G., et al.
Publicado: (2022)

Anti-trypanosomal activity of non-peptidic nitrile-based cysteine protease inhibitors
por: Burtoloso, Antonio C. B., et al.
Publicado: (2017)

Human defensin-inspired discovery of peptidomimetic antibiotics
por: Luo, Gan, et al.
Publicado: (2022)

Boroleucine‐Derived Covalent Inhibitors of the ZIKV Protease
por: Braun, Niklas J., et al.
Publicado: (2022)

Development of Peptidomimetics Targeting IAPs
por: Sharma, Sushil K., et al.
Publicado: (2006)

Using the ribosome to synthesize peptidomimetics
por: Freidinger, Roger M
Publicado: (2009)

Short Cationic Peptidomimetic Antimicrobials
por: Kuppusamy, Rajesh, et al.
Publicado: (2019)

Promising Antibiofilm Activity of Peptidomimetics
por: Gomes Von Borowski, Rafael, et al.
Publicado: (2018)

Peptidomimetics Therapeutics for Retinal Disease
por: Parsons, Dylan E., et al.
Publicado: (2021)

Cell-free Biosynthesis of Peptidomimetics
por: Lee, Kanghun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g2s19amvvvg064b45obsvjoitv